CD274 and endocrine system disorder: To evaluate the clinical factors that affect the therapeutic efficacy of PD-L1 positive ICI immunotherapy, we conducted a univariate COX regression analysis on the collected clinical information of patients, and the results showed that clinical stage, presence of distant metastasis, endocrine system diseases history, whether immunotherapy is first-line treatment, and white blood cell count can significantly affect PFS.